Dr. Tessy K. Paul, MD

Dr. Paul practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Paul's NPI, 1063671105, was assigned on June 4, 2008. Dr. Paul graduated from University of Maryland School of Medicine in 2008. Dr. Paul holds Virginia license 0101258648.

Dr. Paul's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Paul's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Paul is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Paul to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paul practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Paul's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Paul's licenses on file in 2 states: Virginia and Maryland.

CMS data shows 594 Medicare services from Dr. Paul across 11 procedure codes in 2024, for 266 Medicare patients. Medicare paid $36,463 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 266 Medicare patients who saw Dr. Paul in 2024. The largest group is 75 to 84, with 118 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paul's median patient age at 65, with 57% women.

In 2024, Dr. Paul wrote 575 Medicare Part D claims for 107 patients. 58% of them were for generic drugs. CMS names the drug for 453 of them, across 16 drugs with 11 or more claims each, at $1,022,791 in total drug cost. In 2023, CMS named 445 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Paul for performance year 2024, reported as part of a group. Dr. Paul accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paul as offering telehealth.

Dmand AI links 4 papers to Dr. Paul in 2024. 2024 was the busiest year, with 2. Dr. Paul's most frequent co-authors are Robert J. Kaner, MD, Monika Maria Safford, MD and Anthony Francis Arredondo, MD.

Dmand AI links Dr. Paul to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 7 general payments to Dr. Paul from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 96% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $318.

Dr. Paul graduated from University of Maryland School of Medicine in 2008.